Enzolytics, Inc. (ENZC)
OTCMKTS · Delayed Price · Currency is USD
0.00035
-0.0001 (-12.50%)
May 4, 2026, 12:40 PM EST
Enzolytics Market Cap
Enzolytics has a market cap or net worth of $1.69 million as of May 6, 2026. Its market cap has decreased by -50.00% in one year.
Market Cap
1.69M
Enterprise Value
n/a
Revenue
46.59K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 29, 2008, Enzolytics's market cap has decreased from 106.80M to 1.69M, a decrease of -98.42%. That is a compound annual growth rate of -21.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 1.69M | 16.67% |
| Dec 31, 2025 | 1.45M | -68.42% |
| Dec 31, 2024 | 4.59M | -91.73% |
| Dec 29, 2023 | 55.53M | -46.84% |
| Dec 30, 2022 | 104.44M | -45.90% |
| Dec 31, 2021 | 193.06M | -12.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VitaSpring Biomedical | 2.30M |
| ProtoKinetix | 2.21M |
| Burzynski Research Institute | 2.15M |
| Iterum Therapeutics | 2.07M |
| Avenue Therapeutics | 2.00M |
| AXIM Biotechnologies | 1.89M |
| Hepion Pharmaceuticals | 1.83M |
| ZyVersa Therapeutics | 1.78M |